A division of pharmaceutical giant Pfizer, Inc., has renewed and expanded its presence at the Hudson Valley iCampus in Pearl River with the signing of leases for a total of 151,069 square feet of space over the next five years.

Pfizer’s Global Supply Division is adding 4,310 square feet to manufacturing, laboratory, warehouse and office space already occupied throughout the 207-acre, 2-million-square-foot campus. Jamie Schwartz, president of Hudson Valley iCampus, said, “Their decision to expand and renew in multiple buildings throughout the campus is a real vote of confidence.”
iCampus is owned by Industrial Realty Group LLC (IRG) and managed by a wholly owned affiliate, IRG Realty Advisors LLC. Schwartz noted that there have been substantial capital investments in the iCampus property by its owner over the past two years.
In addition to renting at iCampus, Pfizer owns 23 acres contiguous to iCampus and announced last year that it will invest $470 million to build a state-of-the art laboratory and office building for its Vaccine Research and Development Division on a portion of the parcel it owns.
iCampus has a street address of 401 North Middletown Road in Pearl River.